Widely used:Recently Viewed
Clear All
Today’s Range
52 Week Range
Liquidity
Market cap
$40,736 Mln
P/E Ratio
29.61
P/B Ratio
4.07
Industry P/E
--
Debt to Equity
0.07
ROE
0.17 %
ROCE
46.27 %
Div. Yield
0 %
Book Value
16.93
EPS
7.07
CFO
$10,283.70 Mln
EBITDA
$11,661.20 Mln
Net Profit
$9,517.50 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
| -5.01 | -7.70 | -5.13 | -23.82 | -14.51 | 3.64 | 11.04 |
|
BSE Sensex
| -3.77 | -0.92 | -6.67 | 3.66 | 9.18 | 19.75 | 10.11 |
|
S&P Midcap 400
| -5.38 | -7.79 | -8.89 | 0.87 | 3.19 | 16.02 | 6.92 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Edwards Lifesciences Corp (EW)
| -2.89 | 2.20 | -42.41 | 42.00 | 17.32 | 52.31 | 35.67 |
|
S&P Midcap 400
| 12.12 | 14.45 | -14.48 | 23.21 | 11.81 | 24.05 | -12.43 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 232.09 | 64,886.77 | 38.04 | 6.76 | |
| 419.53 | 33,775.60 | 38.92 | 57.66 | |
| 220.51 | 32,921.71 | 26.47 | 24.69 | |
| 236.05 | 36,983.33 | 52.73 | 12.96 |
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally... invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Address: One Edwards Way, Irvine, CA, United States, 92614 Read more
CEO & Director
Mr. Bernard J. Zovighian
CEO & Director
Mr. Bernard J. Zovighian
Headquarters
Irvine, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Edwards Lifesciences Corp (EW) stood at $ 13,055 Mln as on 31-Dec-24
The share price of Edwards Lifesciences Corp (EW) is $70.32 (NYSE) as of 18-Mar-2025 15:42 EDT. Edwards Lifesciences Corp (EW) has given a return of -14.51% in the last 3 years.
Edwards Lifesciences Corp (EW) has a market capitalisation of $ 40,736 Mln as on 17-Mar-2025. As per Value Research classification, it is a Mid Cap company.
The P/E ratio of Edwards Lifesciences Corp (EW) is 29.61 times as on 17-Mar-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Edwards Lifesciences Corp (EW) and enter the required number of quantities and click on buy to purchase the shares of Edwards Lifesciences Corp (EW).
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California. Address: One Edwards Way, Irvine, CA, United States, 92614
The CEO & director of Mr. Bernard J. Zovighian. is Edwards Lifesciences Corp (EW), and CFO & Sr. VP is Mr. Bernard J. Zovighian.
There is no promoter pledging in Edwards Lifesciences Corp (EW).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
6,440
|
|
|
3,592
|
|
|
3,571
|
|
|
3,287
|
| Edwards Lifesciences Corp (EW) | Ratios |
|---|---|
|
Return on equity(%)
|
50.15
|
|
Operating margin(%)
|
28.82
|
|
Net Margin(%)
|
76.75
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Edwards Lifesciences Corp (EW) was $4,175 Mln.
$-0.31
(
